Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Lung Cancer

Free Subscription Articles published in J Nucl Med Retrieve available abstracts of 29 articles: HTML format

Single Articles

May 2026
1. NOVRUZOV E, Mamlins E, Widjaja L, Siegmund SC, et al
   Reliability and Practicability of FAP-RADS Version 1.0 for Structured Reporting of FAPI Imaging in Pulmonary and Urothelial Carcinoma.
   J Nucl Med. 2026;67:687-692.
   PubMed     Abstract available
   
   
   April 2026
2. AURIAC J, Lemoudda G, Hovhannisyan-Baghdasarian N, Pires M, et al
   Brain Metabolic Activity Measured by [(18)F]FDG PET/CT Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer.
   J Nucl Med. 2026 Apr 9:jnumed.125.271400. doi: 10.2967/jnumed.125.271400.
   PubMed     Abstract available
   
   
   January 2026
3. CHRISTENSEN TN, Langer SW, Dejanovic D, Gillings N, et al
   Malignancy Detection Rates of [(68)Ga]Ga-SSO120 PET/CT in Patients with Small Cell Lung Cancer and Large Cell Neuroendocrine Lung Cancer.
   J Nucl Med. 2026 Jan 8:jnumed.125.270233. doi: 10.2967/jnumed.125.270233.
   PubMed     Abstract available
   
   
   
4. KESSLER L, Schwaning F, Metzenmacher M, Pabst KM, et al
   Prognostic Value of Fibroblast Activation Protein-Directed PET Imaging in Pleural Mesothelioma.
   J Nucl Med. 2026 Jan 8:jnumed.125.270906. doi: 10.2967/jnumed.125.270906.
   PubMed     Abstract available
   
   
   December 2025
5. DING H, Li L, You D, Mou L, et al
   [(177)Lu]Lu-DOTATATE and [(177)Lu]Lu-DOTA-IBA Cocktail Therapy for Metastatic Small Cell Lung Cancer: Possible Applications in Clinical Practice.
   J Nucl Med. 2025 Dec 30:jnumed.125.271432. doi: 10.2967/jnumed.125.271432.
   PubMed    
   
   
   
6. MA C, Cao M, Li L, Wu Q, et al
   CD70-Targeted [(18)F]RCCB6 Immuno-PET/CT for Diagnosing Clear Cell Renal Cell Carcinoma Metastases: A Prospective Study.
   J Nucl Med. 2025 Dec 11:jnumed.125.270958. doi: 10.2967/jnumed.125.270958.
   PubMed     Abstract available
   
   
   February 2025
7. VERA P, Giraud P, Hapdey S, Gouel P, et al
   Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer.
   J Nucl Med. 2025 Feb 27:jnumed.124.268499. doi: 10.2967/jnumed.124.268499.
   PubMed     Abstract available
   
   
   
8. VIERING O, Holzleitner N, Claus R, Amerein A, et al
   CCK(2) Receptor Ligand [(68)Ga]Ga-DOTA-CCK-66 PET/CT Outperforms [(68)Ga]Ga-DOTATOC PET/CT in a Patient with Small Cell Lung Cancer.
   J Nucl Med. 2025 Feb 20:jnumed.124.269201. doi: 10.2967/jnumed.124.269201.
   PubMed    
   
   
   January 2025
9. ENKE JS, Reitsam NG, Dintner S, Liesche-Starnecker F, et al
   Comprehensive Characterization via Molecular Imaging, Longitudinal Multisite Sampling, and Autoptic Work-up in Advanced Small Cell Lung Cancer Undergoing SSTR-Directed Radiopharmaceutical Therapy.
   J Nucl Med. 2025 Jan 16:jnumed.124.268513. doi: 10.2967/jnumed.124.268513.
   PubMed     Abstract available
   
   
   
10. VRAKA C, Homolya M, Ozer O, Spittler A, et al
    RadioFlow Cytometry Reveals That [(18)F]FDG Uptake in K-RAS Lung Cancer Is Driven by Immune Cells: An Analysis on a Single-Cell Level.
    J Nucl Med. 2025 Jan 16:jnumed.124.268799. doi: 10.2967/jnumed.124.268799.
    PubMed     Abstract available
    
    
    November 2024
11. HUANG W, Cao M, Wu Y, Zhang Y, et al
    Immuno-PET/CT Imaging of Trop2 with [(18)F]AlF-RESCA-T4 Differentiates Lung Cancer from Inflammation.
    J Nucl Med. 2024 Nov 14:jnumed.124.268751. doi: 10.2967/jnumed.124.268751.
    PubMed     Abstract available
    
    
    October 2024
12. LEVI J, Das M, Vasanawala MS, Behl D, et al
    [(18)F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy.
    J Nucl Med. 2024 Oct 24:jnumed.124.268253. doi: 10.2967/jnumed.124.268253.
    PubMed     Abstract available
    
    
    
13. VAN SLUIS J, van Snick JH, Glaudemans AWJM, Slart RHJA, et al
    Ultrashort Oncologic Whole-Body [(18)F]FDG Patlak Imaging Using LAFOV PET.
    J Nucl Med. 2024;65:1652-1657.
    PubMed     Abstract available
    
    
    August 2024
14. OMIDVARI N, Levi J, Abdelhafez YG, Wang Y, et al
    Total-Body Dynamic Imaging and Kinetic Modeling of [(18)F]F-AraG in Healthy Individuals and a Non-Small Cell Lung Cancer Patient Undergoing Anti-PD-1 Immunotherapy.
    J Nucl Med. 2024 Aug 1:jnumed.123.267003. doi: 10.2967/jnumed.123.267003.
    PubMed     Abstract available
    
    
    
15. CAPTIER N, Orlhac F, Hovhannisyan-Baghdasarian N, Luporsi M, et al
    RadShap: An Explanation Tool for Highlighting the Contributions of Multiple Regions of Interest to the Prediction of Radiomic Models.
    J Nucl Med. 2024;65:1307-1312.
    PubMed     Abstract available
    
    
    July 2024
16. KESSLER L, Schwaning F, Metzenmacher M, Pabst K, et al
    Fibroblast Activation Protein-Directed Imaging Outperforms (18)F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial.
    J Nucl Med. 2024 Jul 3:jnumed.124.267473. doi: 10.2967/jnumed.124.267473.
    PubMed     Abstract available
    
    
    June 2024
17. RICH AA, Taunk NK, Mankoff DA, Pantel AR, et al
    [(18)F]Fluoroestradiol Uptake in Irradiated Lung Parenchyma and Draining Nodes.
    J Nucl Med. 2024;65:990-991.
    PubMed    
    
    
    April 2024
18. ROHRICH M, Daum J, Gutjahr E, Spektor AM, et al
    Diagnostic Potential of Supplemental Static and Dynamic (68)Ga-FAPI-46 PET for Primary (18)F-FDG-Negative Pulmonary Lesions.
    J Nucl Med. 2024 Apr 11:jnumed.123.267103. doi: 10.2967/jnumed.123.267103.
    PubMed     Abstract available
    
    
    
19. SCHULER M, Hense J, Darwiche K, Michels S, et al
    Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in EGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance.
    J Nucl Med. 2024 Apr 4:jnumed.123.266979. doi: 10.2967/jnumed.123.266979.
    PubMed     Abstract available
    
    
    March 2024
20. WANG Y, Abdelhafez YG, Spencer BA, Verma R, et al
    High-Temporal-Resolution Kinetic Modeling of Lung Tumors with Dual-Blood Input Function Using Total-Body Dynamic PET.
    J Nucl Med. 2024 Mar 28:jnumed.123.267036. doi: 10.2967/jnumed.123.267036.
    PubMed     Abstract available
    
    
    
21. THOR M, Lee C, Sun L, Patel P, et al
    An (18)F-FDG PET/CT and Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Stage III Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Immunotherapy.
    J Nucl Med. 2024 Mar 14:jnumed.123.266965. doi: 10.2967/jnumed.123.266965.
    PubMed     Abstract available
    
    
    
22. LI C, Chen Q, Tian Y, Chen J, et al
    (68)Ga-FAPI-04 PET/CT in Non-Small Cell Lung Cancer: Accurate Evaluation of Lymph Node Metastasis and Correlation with Fibroblast Activation Protein Expression.
    J Nucl Med. 2024 Mar 7:jnumed.123.266806. doi: 10.2967/jnumed.123.266806.
    PubMed     Abstract available
    
    
    
23. HOVHANNISYAN-BAGHDASARIAN N, Luporsi M, Captier N, Nioche C, et al
    Promising Candidate Prognostic Biomarkers in [(18)F]FDG PET Images: Evaluation in Independent Cohorts of Non-Small Cell Lung Cancer Patients.
    J Nucl Med. 2024 Mar 7:jnumed.123.266331. doi: 10.2967/jnumed.123.266331.
    PubMed     Abstract available
    
    
    
24. CUZZANI G, Fortunati E, Zanoni L, Nanni C, et al
    Case Report: Pulmonary Actinomyces Infection Mimics Lung Cancer on [(68)Ga]Ga-FAPI PET/CT.
    J Nucl Med. 2024 Mar 7:jnumed.123.267155. doi: 10.2967/jnumed.123.267155.
    PubMed    
    
    
    February 2024
25. LEUNG KH, Rowe SP, Sadaghiani MS, Leal JP, et al
    Deep Semisupervised Transfer Learning for Fully Automated Whole-Body Tumor Quantification and Prognosis of Cancer on PET/CT.
    J Nucl Med. 2024 Feb 29:jnumed.123.267048. doi: 10.2967/jnumed.123.267048.
    PubMed     Abstract available
    
    
    
26. BOURBONNE V, Morjani M, Pradier O, Hatt M, et al
    PET/CT-Based Radiogenomics Supports KEAP1/NFE2L2 Pathway Targeting for Non-Small Cell Lung Cancer Treated with Curative Radiotherapy.
    J Nucl Med. 2024 Feb 15:jnumed.123.266749. doi: 10.2967/jnumed.123.266749.
    PubMed     Abstract available
    
    
    
27. LIU Z, Mhlanga JC, Xia H, Siegel BA, et al
    Need for Objective Task-Based Evaluation of Image Segmentation Algorithms for Quantitative PET: A Study with ACRIN 6668/RTOG 0235 Multicenter Clinical Trial Data.
    J Nucl Med. 2024 Feb 15:jnumed.123.266018. doi: 10.2967/jnumed.123.266018.
    PubMed     Abstract available
    
    
    November 2023
28. QUAN Z, Han Z, Yang Y, Wang J, et al
    Noninvasive Monitoring of Immunotherapy in Lung Cancer by Lymphocyte Activation Gene 3 PET Imaging of Tumor-Infiltrating Lymphocytes.
    J Nucl Med. 2023 Nov 16:jnumed.123.266002. doi: 10.2967/jnumed.123.266002.
    PubMed     Abstract available
    
    
    October 2023
29. LI X, Ye J, Wang J, Quan Z, et al
    First-in-Humans PET Imaging of KRAS(G12C) Mutation Status in Non-Small Cell Lung and Colorectal Cancer Patients Using [(18)F]PFPMD.
    J Nucl Med. 2023 Oct 12:jnumed.123.265715. doi: 10.2967/jnumed.123.265715.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum